AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
"lone. Thus, moxifloxacin has attracted interest as a potential therapy for mycoplasmal or chlamydial urogenital infections," scientists in Bordeaux, France report (see also Chlamydia).
"The activity of moxifloxacin was compared with that of other antimicrobial agents against 54 strains of Ureaplasma spp., 54 strains of Mycoplasma hominis, 14 strains of Mycoplasma genitaliuin, and 44 strains of Chlamydia trachomatis. Moxifloxacin inhibited 90% of all isolates at a concentration
The researchers concluded: "Thus, moxifloxacin has attracted interest as a potential therapy for mycoplasmal or chlamydial urogenital infections."
Bebear and colleagues published their study in Clinical Microbiology and Infection (Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clinical Microbiology and Infection, 2008;14(8):801-805).
For additional information, contact C.M. Bebear, University of Victor Segalen Bordeaux 2, CHU Bordeaux, National Reference Center ...